JSPRW 8-K 2026-07-17

Jasper Therapeutics, Inc. (JSPRW) 8-K dated 2026-07-17 — accession 0001213900-26-078887.

Jasper Therapeutics, Inc. (JSPRW) is a biotechnology company listed on US.

Jasper Therapeutics, Inc. filed a 8-K on 2026-07-17. Accession 0001213900-26-078887.

This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Director/officer change (Item 5.02), Bylaws or fiscal year change (Item 5.03), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for JSPRW is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The JSPRW SEC hub lists recent forms. The stock page is the research view.